@ARTICLE{
author={Tiede Andreas,Rosa Cid Ana,Goldmann Georg,Jimenez-Yuste Victor,Pluta Michael,Lissitchkov Toshko,May Marcus,Matytsina Irina,Miljic Predrag S,Pabinger Ingrid,Persson Paula},
year={2020},
title={Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A},
journal={THROMBOSIS AND HAEMOSTASIS},
volume={120},
number={2},
pages={277-288},
document_type={Article},
} 

@ARTICLE{
author={Lentz Steven R,Janic Dragana M,Kavakli Kaan,Miljic Predrag S,Oldenburg Johannes,Ozelo Margareth Castro,Santagostino Elena,Suzuki Takashi,Zupancic-Salek Silva,Korsholm Lars,Matytsina Irina,Tiede Andreas},
year={2018},
title={Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial},
journal={HAEMOPHILIA},
volume={24},
number={6},
pages={E391-E394},
document_type={Article},
} 

@ARTICLE{
author={Santagostino E,Lentz SR,Misgav M,Brand B,Chowdary Pratima,Savic Aleksandar D,Kilinc Yurdanur,Amit Y,Amendola A,Solimeno LP,Saugstrup T,Matytsina Irina},
year={2015},
title={Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials},
journal={HAEMOPHILIA},
volume={21},
number={1},
pages={34-40},
document_type={Article},
}